While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...

Popular party combo linked to colon cancer in young peopleA little-known molecule in the body may be the key to treating ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that senior executives at the pharma ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component of this system are pattern recognition receptors, which recognize non-self ...

Terrana Biosciences will develop crop protection inputs using RNA technology, which was used by Flagship portfolio company Moderna to develop its covid-19 vaccine.

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

Terrana is aiming to have commercially available products in the next few years, pending regulatory approval, that can be applied as sprayables or seed treatments. And the company says its RNA-based ...

For payers, claims for rare disease treatments used to be uncommon. Not anymore, thanks to an increasing number of new, ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...